{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T03:56:17Z","timestamp":1777694177743,"version":"3.51.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005974","name":"Population Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005974","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["5U54HD9990"],"award-info":[{"award-number":["5U54HD9990"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","contraceptionjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Contraception"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.contraception.2021.06.010","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T10:43:50Z","timestamp":1624099430000},"page":"327-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study"],"prefix":"10.1016","volume":"104","author":[{"given":"Vivian","family":"Brache","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2933-5755","authenticated-orcid":false,"given":"Carolina Sales","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlena","family":"Plagianos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maud","family":"Lansiaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Merkatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Cochon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana S","family":"Tejada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narender","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Loeven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana L","family":"Blithe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abi Santhosh","family":"Aprem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair RW","family":"Williams","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5889-8157","authenticated-orcid":false,"given":"Athilakshmi","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Indrani C","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Regine","family":"Sitruk-Ware","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.contraception.2021.06.010_bib0001","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1097\/AOG.0000000000001106","article-title":"Committee Opinion No. 642: Increasing access to contraceptive implants and intrauterine devices to reduce unintended pregnancy.","volume":"126","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.06.010_bib0002","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1056\/NEJMoa1110855","article-title":"Effectiveness of long-acting reversible contraception","volume":"366","author":"Winner","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2021.06.010_bib0003","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0010-7824(94)90109-0","article-title":"Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial","volume":"49","author":"Andersson","year":"1994","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.06.010_bib0004","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.contraception.2016.02.024","article-title":"Safety and efficacy in parous women of a 52-mg levonorgestrel-medicated intrauterine device: a 7-year randomized comparative study with the TCu380A","volume":"93","author":"Rowe","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.06.010_bib0005","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0010-7824(90)90046-X","article-title":"Long-term contraception with the levonorgestrel 20 mcg\/day (LNg 20) and the copper T 380Ag intrauterine devices: a five-year randomized study","volume":"42","author":"Sivin","year":"1990","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.06.010_bib0006","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.contraception.2009.11.004","article-title":"Intrauterine administration of CDB-2914 (Ulipristal) suppresses the endometrium of rhesus macaques","volume":"81","author":"Brenner","year":"2010","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.06.010_bib0007","series-title":"WHO - Medical eligibility criteria for contraceptive use","year":"2015"},{"key":"10.1016\/j.contraception.2021.06.010_bib0008","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0010-7824(86)90006-5","article-title":"The analysis of vaginal bleeding patterns induced by fertility regulating methods. World Health Organization Special Programme of Research, Development and Research Training in Human Reproduction","volume":"34","author":"Belsey","year":"1986","journal-title":"Contraception"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2021.06.010_bib0009","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13625180801959931","article-title":"The effects of Implanon on menstrual bleeding patterns","volume":"13","author":"Mansour","year":"2008","journal-title":"Eur J Contracept Reprod Health Care"},{"key":"10.1016\/j.contraception.2021.06.010_bib0010","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0002-9378(72)90178-0","article-title":"Single luteal phase serum progesterone assay as an indicator of ovulation","volume":"112","author":"Israel","year":"1972","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.contraception.2021.06.010_bib0011","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2011.10.003","article-title":"Effects of a novel estrogen-free, progesterone receptor modulator contraceptive vaginal ring on inhibition of ovulation, bleeding patterns and endometrium in normal women","volume":"85","author":"Brache","year":"2012","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.06.010_bib0012","unstructured":"Kurman R, Carcangiu M, Herrington C, Young R. WHO classification of tumours of female reproductive organs. vol. 6. 4th ed. 2014."},{"key":"10.1016\/j.contraception.2021.06.010_bib0013","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1097\/PGP.0b013e318251035b","article-title":"Endometrial morphology after treatment of uterine fibroids with the selective progesterone receptor modulator, ulipristal acetate","volume":"31","author":"Williams","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.contraception.2021.06.010_bib0014","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0010-7824(96)00273-9","article-title":"Menstrual bleeding patterns in untreated women. Task Force on long-acting systemic agents for fertility regulation","volume":"55","author":"Belsey","year":"1997","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.06.010_bib0015","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(02)07882-0","article-title":"Sample size slippages in randomised trials: exclusions and the lost and wayward","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.contraception.2021.06.010_bib0016","first-page":"106","article-title":"Understanding waterfall plots","volume":"3","author":"Gillespie","year":"2012","journal-title":"J Adv Pract Oncol"},{"key":"10.1016\/j.contraception.2021.06.010_bib0017","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/0010-7824(93)90136-U","article-title":"The long-term effects of copper surface area on menstrual blood loss and iron status in women fitted with an IUD","volume":"48","author":"Larsson","year":"1993","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.06.010_bib0018","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.contraception.2012.09.025","article-title":"Hemoglobin and serum ferritin levels in women using copper-releasing or levonorgestrel-releasing intrauterine devices: a systematic review","volume":"87","author":"Lowe","year":"2013","journal-title":"Contraception"},{"key":"10.1016\/j.contraception.2021.06.010_bib0019","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1177\/1933719117746764","article-title":"Characterization of molecular changes in endometrium associated with chronic use of progesterone receptor modulators: ulipristal acetate versus mifepristone","volume":"25","author":"Kannan","year":"2018","journal-title":"Reprod Sci"},{"key":"10.1016\/j.contraception.2021.06.010_bib0020","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.rbmo.2018.04.040","article-title":"Ulipristal acetate for the management of large uterine fibroids associated with heavy bleeding: a review","volume":"37","author":"Donnez","year":"2018","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/j.contraception.2021.06.010_bib0021","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1093\/humrep\/det467","article-title":"Individualized vaginal bleeding experience of women with uterine fibroids in the PEARL I randomized controlled trial comparing the effects of ulipristal acetate or placebo","volume":"29","author":"Barlow","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/j.contraception.2021.06.010_bib0022","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1056\/NEJMoa1103182","article-title":"Ulipristal acetate versus placebo for fibroid treatment before surgery","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2021.06.010_bib0023","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1056\/NEJMoa1103180","article-title":"Ulipristal acetate versus leuprolide acetate for uterine fibroids","volume":"366","author":"Donnez","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.contraception.2021.06.010_bib0024","unstructured":"EMA. Ulipristal acetate 5mg medicinal products. European Medicines Agency 2020. https:\/\/www.ema.europa.eu\/en\/medicines\/human\/referrals\/ulipristal-acetate-5mg-medicinal-products (accessed September 14, 2020)."},{"key":"10.1016\/j.contraception.2021.06.010_bib0025","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1016\/j.jhep.2019.02.014","article-title":"European Association for the Study of the Liver. EASL Clinical Practice Guidelines: Drug-induced liver injury","volume":"70","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.contraception.2021.06.010_bib0026","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejogrb.2017.04.042","article-title":"Endometrial changes during ulipristal acetate use: A systematic review","volume":"214","author":"De Milliano","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.contraception.2021.06.010_bib0027","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/bjc.2015.453","article-title":"Measuring the biological effect of presurgical metformin treatment in endometrial cancer","volume":"114","author":"Sivalingam","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.contraception.2021.06.010_bib0028","first-page":"531","article-title":"Selective progesterone receptor modulator (SPRM) ulipristal acetate (UPA) and its effects on the human endometrium","volume":"32","author":"Whitaker","year":"2017","journal-title":"Hum Reprod"},{"issue":"Suppl 1","key":"10.1016\/j.contraception.2021.06.010_bib0029","doi-asserted-by":"crossref","first-page":"S123","DOI":"10.1097\/PGP.0000000000000488","article-title":"Interpretation of P53 Immunohistochemistry in Endometrial Carcinomas: Toward Increased Reproducibility","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.contraception.2021.06.010_bib0030","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s12905-018-0627-8","article-title":"A systematic review of methods to measure menstrual blood loss","volume":"18","author":"Magnay","year":"2018","journal-title":"BMC Womens Health"},{"key":"10.1016\/j.contraception.2021.06.010_bib0031","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0015-0282(16)47535-7","article-title":"Diagnosis of luteinized unruptured follicle (LUF) syndrome by ultrasound","volume":"41","author":"Liukkonen","year":"1984","journal-title":"Fertil Steril"}],"container-title":["Contraception"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421001931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010782421001931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T21:11:52Z","timestamp":1762117912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010782421001931"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0010782421001931"],"URL":"https:\/\/doi.org\/10.1016\/j.contraception.2021.06.010","relation":{},"ISSN":["0010-7824"],"issn-type":[{"value":"0010-7824","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacodynamics and pharmacokinetics of a copper intrauterine contraceptive system releasing ulipristal acetate: A randomized proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"Contraception","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.contraception.2021.06.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}